Lexicon Pharmaceuticals, Inc.LXRXNASDAQ
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank14
3Y CAGR-84.4%
5Y CAGR-4.2%
Year-over-Year Change
Enterprise value to sales ratio
3Y CAGR
-84.4%/yr
vs +270.3%/yr prior
5Y CAGR
-4.2%/yr
Recent deceleration
Acceleration
-354.7pp
Decelerating
Percentile
P14
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
3 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 8.94 | -0.0% |
| 2024 | 8.95 | -97.4% |
| 2023 | 350.44 | -85.0% |
| 2022 | 2341.72 | +36.3% |
| 2021 | 1718.40 | +15423.1% |
| 2020 | 11.07 | +447.2% |
| 2019 | 2.02 | -83.8% |
| 2018 | 12.45 | +15.5% |
| 2017 | 10.78 | -24.6% |
| 2016 | 14.30 | - |